The objective of this paper was to study the therapeutic effect of Stigma maydis polysaccharides in diabetic mice.
Introduction
convergence activity, zeaxanthin that have vitamin A activity and other nutrient substances and effective constituents, which can be used in the treatment of hypertension, nephritis, gallstone, diabetes, jaundice, measles, etc.
With the improvement of living standards, diabetes mellitus, which is closely related to people's living standards, has become a third common chronic disease causing serious harm to human health after tumours and cerebrovascular diseases in the world. The World Health Organisation (WHO) has listed diabetes mellitus as one of the world's three major difficult diseases, and designated November 14 of each year as "World Diabetes Day". Analysing from the pathological point of view, diabetes can be divided into type 1 and type 2. In the type 1 diabetes, islet function is completely lost, and this requires insulin treatment. In the type 2 diabetes, glucose tolerance is impaired mainly due to the relative lack of insulin secretion or insulin resistance, and this requires treatment with insulin secretion promoting drugs (such as sulfonylurea hypoglycaemic agents) or insulin sensitizers. Diabetes need long-term or lifelong control by drugs, but some chemical drugs used at present for the treatment of diabetes have some serious adverse reactions if used long-term. Such serious adverse reactions include severe hypoglycaemia, anaphylactic shock, liver damage, cardiovascular toxicity, etc. Therefore, the development of drugs 
Materials and Methods

Drugs and reagents
Stigma maydis (collected from Wafangdian region) was identified by Professor Jinshan Liu (Zhengzhou University).
Reagents include alloxan (Sigma), metformin (Aohua, Shenyang), glucose (Beijing Chemical Works), and blood glucose kit (Yilikang Biotechnology Co., Ltd., Wenzhou). Other reagents were domestic products of analytical grade.
Main instruments
The instruments used for the experiment are as follows: KQ-250DE medical CNC ultrasonic instrument (Kunshan Ultrasonic Instrument Co., Ltd.); low-temperature refrigerated centrifuge (Eppendorf, Germany); rotary evaporator (SENCO Technology Co. Ltd., Shanghai); 101A-1B thermostatic drying oven (Shanghai Instrument Co., Ltd.); electronic balance (Sartorius AG, Beijing); and blood glucometer (ACCU-CHEK-Active, Germany).
Experimental animals
SPF km male mice, weighing 20 ± 2g, were provided by the Laboratory Animal Center of China Medical University.
All experimental procedures were approved by the Animal Research Ethics Committee.
Ultrasonic extraction and purification of Stigma maydis polysaccharides (Liang et al., 2011) 500 g of Stigma maydis
were taken, added with an appropriate amount of distilled water and soaked for 24 h. Water was added to make the solid-liquid ratio 1:30, followed by ultrasonic extraction at 60 ℃ for 60 min four times. Then, the extracts were combined, cooled to room temperature, and filtered with four-layer gauze. The resulting filtrate was centrifuged at 3000 r/min for 20 min. The supernatant was taken, transferred to a rotary evaporator in batches and concentrated to 2000 mL. The concentrate was added with anhydrous ethanol to 80% and allowed to stand for 24 h at 4℃. It was then centrifuged at 3000 r/min for 10 min. The precipitate was crude polysaccharides, which were then decolorized by D101 macroporous resin, deproteinized by SEVAGE method, washed several times with anhydrous ethanol, ethyl ether and acetone, and dried to powder in a 60 ℃ vacuum oven to obtain 25.132 g of grey-white Stigma maydis polysaccharides.
Establishment of diabetic mice model
In reference to the literature (Frode and were adapted to the feeding for 3 d. Then, 6 mice were randomly picked as the blank control group, and the remaining mice were fed with a high fat diet for 1 month. After an overnight fast, the modelling was continued with low-dose alloxan (90 mg/kg, intraperitoneal injection). 2 d later, blood was sampled from caudal vein to determine the blood glucose level 8 h after fasting. Mice with blood glucose≥10 mmol/L were regarded as the successful experimental animal of type 2 diabetes model.
Grouping and administration
The successfully modelled mice were divided into six groups to give a total of seven groups together with the blank control group. They were administered for four weeks, and the arrangements are as follows:
(1) Blank control group, administered with equal volume of distilled water, denoted by B 
Measurement of food intake, water intake and body weight change
Mice were intragastrically fed once a day for 28 consecutive days. The water intake, food intake and body weight of mice were recorded once every 4 d, and the nutritional status of the mice in each group was observed.
Determination of glucose level
Blood was sampled from hyperglycaemic model mice on the 7th, 14th, 21st and 28th days after the administration, and blood glucose level was directly measured with blood glucometer.
Oral glucose tolerance test
After four weeks of administration, the mice were fasted for 6 h. Then, blood was collected from caudal vein. Serum was separated by centrifugation; 2.0 g/kg glucose was orally administered to determine the blood glucose levels before administration and 0.5, 1 and 2 h after administration. The changes in the glucose tolerance in each group were studied, and graphs were plotted by analysing the data.
Data analysis
Data were processed using SPSS 11.5 software, and were expressed as mean ± SD. Independent sample T-test was used for comparison of test groups and control groups, and significance levels of 0.01 and 0.05 were chosen. Hypoglycaemic data were analysed using one-way ANOVA.
Results
Effects of Stigma maydis polysaccharides on appearance, body weight, food intake and water intake of diabetic mice
After successful modelling, types 1 and 2 diabetic mice both showed varying degrees of mental depression, lustreless body complexion, slow response and other symptoms, and complicated with typical symptoms of "polyuria, polydipsia, polyphagia, weight loss". In comparison, mice in the normal control group had bright fur and hair, good spirit, normal reaction, and did not show the typical symptoms of "polyuria, polydipsia, polyphagia, weight loss". Body weight of type 1 fodiabetic mice in each group is shown in Figure 1 . The body weight of mice in M1 group was significantly lower than that in group B, which was in a gradual downward trend, and the trend of weight loss of mice in D1 group was significantly inhibited by Stigma maydis polysaccharides. Water intake and food intake status of type 1 diabetic mice are as shown in Figure 2 and Figure 3 . At the beginning, the water intake in D1 group was lower than that in M1 group, but there was no significant change. After 8-16 d of administration, the water intake in D1 group was significantly lower than the M1 group (P<0.05). Meanwhile, starting from the 12th day, the food intake in Dl group was also significantly lower than M1 group. The experimental results indicated that the Stigma maydis polysaccharides can improve the weight loss, polydipsia and polyphagia symptoms of type 1 diabetic mice to a significant extent. 
Results for oral glucose tolerance test
The test results of the oral glucose tolerance are as shown in Figure 6 . After administration of glucose, glucose levels of mice in each group were all significantly elevated. Compared separately with M1 and M2 groups, the glucose concentration values of mice in D1 and D2 groups were significantly lower than each model control group, and higher than B group. The trends of blood glucose level rise of mice in D1 and D2 groups after 0.5, 1 and 2 h were significantly inhibited. years, its incidence has been in a gradually increasing trend. At present, chemosynthetic hypoglycaemic drugs are generally used in the treatment, and these drugs are not conducive to long-term medication of diabetes patients (Zhang, 2009 ). Alloxan is a kind of β-cytotoxic agent, which has a selective damaging effect on pancreatic β cells, thereby enabling the incidence of diabetes in mice. Because of its small tissue toxicity and high animal survival rate, it has become one of the commonly used methods for preparation of diabetic animal model currently at home and abroad. This animal model can well reflect the actions and effects of various hypoglycaemic drugs.
In this experiment, Stigma maydis polysaccharides were extracted using ultrasonic method to avoid breakdown of the polysaccharides by high temperature and to observe its effect on blood glucose of diabetic mice. It can be seen from the experiment results that the Stigma maydis polysaccharides have certain hypoglycaemic effect on diabetic mice and can improve weight loss and polydipsia symptoms of diabetic mice. But its hypoglycaemic effect was less significant than that of the positive control drugs. Stigma maydis polysaccharides have an obvious antagonistic effect on alloxan-induced elevated blood glucose, and a significant hypoglycaemic effect on diabetic mice. The glucose tolerance test also showed very good effects of Stigma maydis polysaccharides in suppression and prevention of acute hyperglycaemia, which may be as a result of the combined biological effect of multiple pathways such as glucose metabolism, lipid metabolism and insulin. Stigma maydis is extremely rich in resources. If fully utilised, it will be turning waste into treasure and can well serve the health of majority of the people.
